Introduction {#s0001}
============

Colorectal cancer (CRC) is the third most common cancer worldwide and one of the main reasons for cancer-related death \[[@CIT0001]\]. During decades, Denmark has had poorer CRC survival than other Nordic countries. This may partly be explained by late stage of disease at diagnosis \[[@CIT0002]\]. In an attempt to identify cancer at earlier stages and thereby improve the CRC prognosis, a screening programme based on the use of the faecal immunochemical test (FIT) was implemented in March 2014 for individuals aged 50-74 years \[[@CIT0003]\].

For individuals participating in the screening, recent questionnaire studies have indicated that lower gastrointestinal (GI) symptoms are prevalent in up to 70-80% of the individuals with a positive faecal test \[[@CIT0004]\]. If this is true, these individuals may be detected before entering the screening programme through symptomatic presentation in general practice if the general practitioner (GP) had access to the FIT and thus, providing the opportunity to detect the CRC earlier.

For individuals invited to, but not participating in the screening, studies indicate that general practice will play a key role in the detection of CRC \[[@CIT0007]\]. However, so far, no study has investigated the amount of CRCs occurring outside the Danish screening programme in the invited population, but for GPs this is of special interest since non-participants diagnosed with CRC may have low socio-economic status (SES) and poor CRC prognosis \[[@CIT0008]\].

Thus, the aim of this study was to investigate the diagnostic activity in general practice and the cumulative incidence of CRC in individuals invited to the Danish national screening programme for CRC.

Material and methods {#s0002}
====================

Study design {#s0003}
------------

We conducted a historical population-based cohort study using registry data to assess the diagnostic activity in general practice and the cumulative incidence of CRC.

Setting {#s0004}
-------

From March 2014, CRC screening is being implemented over a 4-year period in Denmark and will be offered biennially after full implementation. The screening is free of charge and uses the FIT as a first line test, which is followed by colonoscopy (or alternatively CT-colonography) if the FIT is positive (≥100μg/L).

All citizens aged 50-74 years are invited to participate in the screening. Citizens participate by performing a FIT received in an invitational letter. The order in which citizens are invited is random and determined on the basis of their month of birth. However, citizens turning 50 or 74 years during the prevalence screening must receive a screening invitation before that particular birthday.

General practice is not involved in any part of the Danish screening programme for CRC. In Denmark, access to general practice is free of charge at the point of care and almost 99% of Danish citizens are listed with a general practice \[[@CIT0011]\].

Study population {#s0005}
----------------

All individuals invited to screening for CRC from 1 March to 31 December 2014 were eligible for inclusion. To ensure complete follow-up, we excluded individuals who were not listed with a GP, had lived outside Denmark at some point during the year preceding the screening invitation or had died within one month after receiving the invitation. Furthermore, to ensure a homogeneous population, we restricted the analyses to individuals without a previous diagnosis of colorectal disease (CRC, Crohn's disease, ulcerative colitis, familial adenomatous polyposis (FAP), hereditary nonpolyposis colorectal cancer (HNPCC) or adenomas followed by regular colonoscopy).

Outcome measures {#s0006}
----------------

*Diagnostic activity in general practice:* Daytime face-to-face consultations (incl. home visits) and point-of-care haemoglobin measurements in general practice (photometric analysis) were used as proxies for diagnostic activity in general practice related to gastrointestinal symptoms and signs, and assessed in the year preceding the screening invitation. The outcome was compared for participants vs. non-participants, individuals with positive FIT vs. individuals with negative FIT and CRC cases vs. non-CRC cases.

*Cumulative incidence of CRC:* Number of CRC diagnoses among individuals invited to screening in the year following the screening invitation. The CRC incidence was stratified into three subgroups: participants diagnosed in the screening, participants diagnosed outside the screening and non-participants.

Data collection {#s0007}
---------------

Data on diagnostic activity was collected from the Danish National Health Service Register until three years preceding the screening invitation to allow for extension of the study period if differences were present for more than one year \[[@CIT0012]\]. The database holds no information on results of laboratory analyses.

Data on CRC (ICD-10: DC180-9 and DC200-9) and UICC stages was collected from the Danish Cancer Registry from the day of invitation until one year following the screening invitation \[[@CIT0013],[@CIT0014]\].

The Danish Colorectal Cancer Screening Database (DCCSD) provided information on the screening invitation, FIT results, performed colonoscopy or CT-colonography and screen-detected CRCs \[[@CIT0015]\].

The Danish National Patient Register (NPR) was used to identify previous diagnoses of colorectal disease (Crohn's disease (ICD-10: DK500-9), ulcerative colitis (ICD-10: DK510-9), FAP (ICD-10: DD126F), HNPCC (ICD-10: DC188A) and adenomas followed by regular colonoscopy (ICD-10: DZ018B) \[[@CIT0016]\]. Furthermore, the NPR was used to identify diagnoses for generating the Charlson Comorbidity Index, which was categorised into "low" (CCI score = 0), "moderate" (CCI score = 1-2) and "severe" (CCI score = ≥3) (CCI) \[[@CIT0017],[@CIT0018]\].

The Danish National Prescription Registry was used to collect information on prescriptions for medications against haemorrhoids (ATC: C05A) or drugs with anticoagulatory effect (NSAIDs (ATC: M01A), acetylsalicylic acids (ATC: B01AC06, N02BA01, N02BA51) and anticoagulants (ATC: B01A)) as these covariates were considered potential confounders for the outcomes \[[@CIT0019]\].

Statistics Denmark provided data on vital status, socio-economic characteristics and demographic factors \[[@CIT0020]\]. Marital status was dichotomised into living with a partner ("married/cohabitating") or living alone ("alone"). Country of origin was categorised into \"Danish", "immigrant from a western country" or "immigrant from a non-western country". Labour market affiliation was categorised into "working", "unemployed" or "retirement pension". Educational level was categorised into "basic" (\<10 years), "medium" (10-15 years) and "high" (\>15 years) \[[@CIT0021]\].

All data were linked by the civil registration number \[[@CIT0022]\].

Statistical analysis {#s0008}
--------------------

The index date was defined as the date the individual was invited to screening for CRC.

The diagnostic activity in general practice was investigated in the year preceding the screening invitation by estimating the consultation rates and haemoglobin measurements rates. This was done in intervals of three months. The diagnostic activity was compared between subgroups by estimating incidence rate ratios (IRRs) using negative binomial regression models with cluster robust variance estimation to account for heterogeneity between individuals. Estimates of the IRRs were adjusted for age, gender, marital status, country of origin, level of education, labour market affiliation, comorbidity, prescriptions of medicine against haemorrhoids and prescriptions of medicine with an anticoagulatory effect.

The cumulative incidence of CRC among individuals invited to screening was investigated in three subgroups to allow assessment of the number of CRCs diagnosed outside the screening programme. CRCs diagnosed among participants outside the screening programme were defined as; a CRC diagnosis after a negative FIT in the screening, or a CRC diagnosis registered in the DCR for an individual with a positive FIT in the screening, but no registered CRC diagnosis in the DCCSD.

In addition, we compared participants' and non-participants' risk of being diagnosed with a stage IV CRC by using a Poisson regression model with time at risk as exposure while taking into account the competing risk of getting a lower stage cancer.

All analyses were performed on the server of Statistics Denmark using Stata 14.0.

Ethical approvals {#s0009}
-----------------

The study was approved by the Danish Data Protection Agency (j.no. 2014-41-3143).

Results {#s0010}
=======

Diagnostic activity in the year preceding the screening invitation {#s0011}
------------------------------------------------------------------

In total, 390,552 individuals were invited to screening from 1 March 2014 to 31 December 2014. After exclusions, 376,198 individuals were included in the analyses ([Figure 1](#F0001){ref-type="fig"}). Among the 245,299 (65%) participants, 16,206 (6.6%) had a positive FIT result and 907 (6.1%) of individuals who had a colonoscopy or CT-colonography performed were diagnosed with CRC ([Figure 1](#F0001){ref-type="fig"}).

![Flowchart of the study population. The number of CRC diagnoses for each subgroup is stated for the year following the screening invitation.](IPRI_A_1487378_F0001_C){#F0001}

*Participants vs. non-participants:* Participants in screening were more often females and had higher SES and less comorbidity than non-participants ([Table 1](#t0001){ref-type="table"}). During the year preceding the screening invitation, participants had significantly higher consultation rates and haemoglobin measurements than non-participants ([Figure 2(A)](#F0002){ref-type="fig"}). This was also seen when extending the study period to three years (results not shown).

![(A-C) Mean rates of daytime face-to-face consultations and haemoglobin measurements for subgroups in the screening for CRC. Estimates are for 3-month intervals, 12 months preceding invitation to screening. The upper graph illustrates the unadjusted average consultation rate for individuals in subgroups. The lower graph illustrates the IRRs for comparison of subgroups adjusted for age, gender, country of origin, educational level, labour market affiliation, marital status, CCI score, prescriptions of medicine against haemorrhoids, NSAIDs, acetylsalicylic acids and anticoagulant drugs.](IPRI_A_1487378_F0002_C){#F0002}

###### 

Characteristics of individuals included in the analyses on diagnostic activity.

                                                            Participants   Non-participants   Positive FIT   Negative FIT   Colorectal cancer   No colorectal cancer                                          
  --------------------------------------------------------- -------------- ------------------ -------------- -------------- ------------------- ---------------------- --------- ------ ----- ------ -------- ------
  Total                                                     245,299                           130,899                       16,206                                     229,093          907          13,955    
  Gender[†](#TF1){ref-type="table-fn"}                                                                                                                                                                        
   Male                                                     113,632        46.3               71,912         54.9           9,083               56.1                   104,549   45.6   538   59.3   7,781    55.8
   Female                                                   131,663        53.7               58,978         45.1           7,123               43.9                   124,540   54.4   369   40.7   6,174    44.2
  Age (years)                                                                                                                                                                                                 
   50-54                                                    83,138         33.9               54,306         41.5           3,467               21.4                   79,671    34.8   87    9.6    3,154    22.6
   55-59                                                    35,887         14.6               18,727         14.3           1.910               11.8                   33,977    14.8   77    8.5    1,695    12.2
   60-64                                                    35,599         14.5               16,003         12.2           2,392               14.7                   33.207    14.5   126   13.9   2,102    15.1
   65-69                                                    39,734         16.2               15,903         12.2           3,254               20.1                   36,480    15.9   198   21.8   2,794    20.0
   70-74                                                    50,941         20.8               25,960         19.8           5,183               32.0                   45,758    20.0   419   46.2   4,210    30.2
  Country of origin                                                                                                                                                                                           
   Danish                                                   229,909        93.7               118,402        90.5           15,360              94.8                   214,549   93.7   881   97.1   13,233   94.8
   Immigrant (western)                                      7,569          3.1                5,486          4.2            468                 2.9                    7,101     3.1    19    2.1    385      2.8
   Immigrant (non-western)                                  7,821          3.2                7,011          5.3            378                 2.3                    7,443     3.3    7     0.8    337      2.4
  Educational level                                                                                                                                                                                           
   Basic                                                    65,204         26.6               46,202         35.3           5,048               31,1                   60,156    26.3   295   32.5   4,258    30.5
   Medium                                                   121,980        49.7               59,217         45.2           8,273               51.1                   113,707   49.6   467   51.5   7,143    51.2
   High                                                     58,115         23.7               25,480         19.5           2,885               17.8                   55,230    24.1   145   16.0   2,554    18.3
  Labour marked affiliation[†](#TF1){ref-type="table-fn"}                                                                                                                                                     
   Working                                                  136,066        55.5               66,792         51.0           6,576               40.6                   129,490   56.5   310   34.2   5,924    42.5
   Unemployed                                               37,298         15.2               29,619         22.6           2,691               16.6                   34,607    15.1   88    9.7    2,324    16.7
   Pension                                                  71,931         29.3               34,479         26.4           6,939               42.8                   64,992    28.4   509   56.1   5,707    40.9
  Marital status[†](#TF1){ref-type="table-fn"}                                                                                                                                                                
   Married/cohabiting                                       184,196        75.1               77,840         59.5           11,526              71.1                   172,670   75.4   665   73.3   10,099   72.4
   Single/living alone                                      61,099         24.9               53,050         40.5           4,680               28.9                   56,419    24.6   242   26.7   3,856    27.6
  Charlson Comorbidity Index                                                                                                                                                                                  
   Low                                                      186,198        75.9               95.442         72.9           10,591              65.4                   175,607   76.7   614   67.7   9,272    66.4
   Moderate                                                 47,443         19.3               26,000         19.9           4,109               25.3                   43,334    18.9   226   24.9   3,477    24.9
   Severe                                                   11,658         4.8                9,457          7.2            1,506               9.3                    10,152    4.4    67    7.4    1,206    8.6
  Prescription for medicine against haemorrhoids                                                                                                                                                              
   No                                                       236,184        96.3               127,613        97.5           15,521              95.8                   220,663   96.3   870   95.9   13,396   96.0
   Yes                                                      9,115          3.7                3,286          2.5            685                 4.2                    8,430     3.7    37    4.1    559      4.0
  Prescription for NSAID                                                                                                                                                                                      
   No                                                       194,067        79.1               105,945        80.9           12,479              77.0                   181,588   79.3   743   81.9   10,691   76.6
   Yes                                                      51,232         20.9               24,954         19.1           3,727               23.0                   47,505    20.7   164   18.1   3,264    23.4
  Prescription for acetylsalicylic acids                                                                                                                                                                      
   No                                                       214,396        87.4               114,097        87.2           12,942              79.9                   201,454   87.9   729   80.4   11,214   80.4
   Yes                                                      30,903         12.6               16,802         12.8           3,264               20.1                   27,639    12.1   178   19.6   2,741    19.6
  Prescription for anticoagulant drugs                                                                                                                                                                        
   No                                                       228,729        93.2               120,686        92,2           13,955              86.1                   214,774   93.8   803   88.5   12,091   86.6
   Yes                                                      16,570         6.8                10,213         7.8            2,251               13.9                   14,319    6.2    104   11.5   1,864    13.4

Information on gender, labour marked affiliation and marital status were missing for 13 individuals.

*Individuals with positive FIT vs. individuals with negative FIT:* More males than females had a positive FIT in screening. In addition, individuals with a positive FIT had lower SES, higher CCI score and more often received medicine with an anticoagulatory effect ([Table 1](#t0001){ref-type="table"}). Higher consultation rates were seen for individuals with a positive FIT compared to individuals with a negative FIT, but also a small insignificant increase in the last three months preceding the screening invitation compared with the three-month period earlier ([Figure 2(B)](#F0002){ref-type="fig"}). The rate of haemoglobin measurements was generally higher for individuals with positive FIT, also with an insignificant increase in the last three months.

*Individuals with colorectal cancer vs. individuals with no colorectal cancer:* Individuals diagnosed with a screen-detected CRC were more often males and of higher age than individuals with no CRC ([Table 1](#t0001){ref-type="table"}). The consultation rates were lower for individuals who were diagnosed with CRC compared to individuals without CRC ([Figure 2(C)](#F0002){ref-type="fig"}). This did not change if the rates were stratified for CRC stages and was seen constantly if the study period was extended to three years (data not shown). There were no significant differences in the rates of haemoglobin measurements.

Cumulative incidence of CRC in the year following the screening invitation {#s0012}
--------------------------------------------------------------------------

One year after the screening invitation, 239 (0.18%) non-participants and 976 (0.40%) participants had been diagnosed with CRC. Among participants, 69 CRC incidents were diagnosed outside the screening programme ([Figure 3](#F0003){ref-type="fig"}) implying that in total; 308 (25.3%) of the CRCs diagnosed within the first year after the invitation were identified outside the screening programme.

![Cumulative incidence of CRC among individuals invited for screening participation, one year following invitation. Incidence was stratified for screening participation. In total, 907 CRCs were diagnosed in the screening (red curve) and 308 CRCs were diagnosed outside the screening (blue and green curves).](IPRI_A_1487378_F0003_C){#F0003}

The characteristics of individuals diagnosed with CRC in the year following the screening invitation are shown in [Table 2](#t0002){ref-type="table"}. Non-participants with CRC were more likely to have low SES and to have higher CCI score compared to participants. The overall risk of being diagnosed with a stage IV CRC was 0.021% (95% confidence interval (95%CI): 0.015; 0.027) for participants and 0.035% (95%CI: 0.026; 0.047) for non-participants, corresponding to a 67% increased risk of late stage (data not shown).

###### 

Characteristics for individuals diagnosed with CRC in the year following the screening invitation.

                               Participants diagnosed with CRC in the screening   Participants diagnosed with CRC outside the screening   Non-participants diagnosed with CRC                
  ---------------------------- -------------------------------------------------- ------------------------------------------------------- ------------------------------------- ------ ----- ------
  Total                        907                                                                                                        69                                           239    
  Gender                                                                                                                                                                                     
   Male                        538                                                59.3                                                    35                                    50.7   147   61.5
   Female                      369                                                40.7                                                    34                                    49.3   92    38.8
  Age (years)                                                                                                                                                                                
   50-54                       87                                                 9.6                                                     10                                    14.5   28    11.7
   55-59                       77                                                 8.5                                                     0                                     --     14    5.9
   60-64                       126                                                13.9                                                    9                                     13.0   47    19.7
   65-69                       198                                                21.8                                                    22                                    31.9   38    15.9
   70-74                       419                                                46.2                                                    28                                    40.6   112   46.8
  Country of origin                                                                                                                                                                          
   Danish                      881                                                97.1                                                    66                                    95.7   230   96.2
   Immigrant (western)         19                                                 2.1                                                     3                                     4.3    NA    --
   Immigrant (non-western)     7                                                  0.8                                                     0                                     --     NA    --
  Educational level                                                                                                                                                                          
   Basic                       295                                                32.5                                                    24                                    34.8   84    35.1
   Medium                      467                                                51.5                                                    35                                    50.7   109   45.6
   High                        145                                                16.0                                                    10                                    14.5   46    19.3
  Labour market affiliation                                                                                                                                                                  
   Working                     310                                                34.2                                                    21                                    36.2   75    31.4
   Unemployed                  88                                                 9.7                                                     8                                     13.8   41    17.1
   Pension                     509                                                56.1                                                    29                                    50.0   123   51.5
  Marital status                                                                                                                                                                             
   Married/cohabiting          665                                                73.3                                                    53                                    76.8   141   59.0
   Single/living alone         242                                                26.7                                                    16                                    23.2   98    41.0
  Charlson Comorbidity Index                                                                                                                                                                 
   Low                         614                                                67.7                                                    45                                    65.2   144   60.3
   Moderate                    226                                                24.9                                                    17                                    24.6   60    25.1
   Severe                      67                                                 7.4                                                     7                                     10.1   35    14.6
  UICC stage                                                                                                                                                                                 
   I                           246                                                27.1                                                    24                                    10.0   10    14.5
   II                          160                                                17.6                                                    40                                    16.7   12    17.4
   III                         171                                                18.9                                                    51                                    21.3   13    18.8
   IV                          51                                                 5.6                                                     46                                    19.3   13    18.9
   Unknown                     279                                                30.8                                                    78                                    32.7   21    30.4

Discussion {#s0013}
==========

Principal findings {#s0014}
------------------

Compared to non-participants, screening-participants had higher SES and a higher diagnostic general practice activity in the year preceding the screening. Individuals with a positive FIT had lower SES, more comorbidity and a higher diagnostic activity compared to individuals with a negative FIT. This group also showed a small increase in the three months preceding screening. Individuals diagnosed with CRC in the screening had lower diagnostic activity than individuals with no CRC.

As expected, the screening helped identify cases of CRC. However, approx. 25% of the CRCs diagnosed in the year following the screening invitation were found outside the screening programme. Non-participants with CRC were more likely to have low SES and more comorbidity and had a 67% increased risk of being diagnosed with a stage IV CRC.

Strengths and weaknesses {#s0015}
------------------------

A major strength of the study was the large study population. This, together with analysing the diagnostic activity in three-month intervals, ensured a high statistical power for these analyses. However, using three-month intervals might have hidden more abrupt changes in the activity. Therefore, we also performed the analyses with monthly intervals, but this did not change the overall findings and estimates.

Using daytime face-to-face consultations and hemoglobin measurements as proxies for presentation of gastrointestinal symptoms and signs in general practice has both advantages and disadvantages. The approach has previously been used in similar studies and is therefore a well-investigated and accepted method \[[@CIT0023],[@CIT0024]\]. These previous studies have shown that CRC patients visit their GP more than the average population in the time leading up to the diagnosis. Using the Danish National Health Service Register for collecting information on general practice consultations enabled us to leave out consultations with preventive focus as these have specific codes in the register. Therefore consultations in this study can be considered as "new events" of symptoms and disease \[[@CIT0012]\]. However, some contacts may have been due to other symptoms than GI-symptoms.

In general, we consider the internal validity of the study to be high. Information bias was diminished by using Danish registers as the primary data source. These databases contain data collected prospectively and independently of this study. However, the DCCSD is a rather newly established database and a recently published paper has shown a sensitivity for CRC of 72%. Therefore, some screen-detected CRC diagnoses may have been missed and overestimated the amount of CRC found outside screening \[[@CIT0015]\]. Selection bias was minimal due to the random order in which individuals were invited to screening and that all citizens are invited regardless of SES and morbidity. However, we cannot rule out that some selection occurred in relation to who chose to participate in the screening. Furthermore, some of the difference found between subgroups regarding SES and comborbidity may be related to differences in age between the groups. Finally, we cannot rule out the presence of residual confounding from comorbidity and medicine with anticoagulatory effect. Firstly, the CCI score accounts for only 17 comorbid conditions and are based on diagnoses from secondary care. Therefore, it may leave out additional comorbidity that could be a reason for increased health-care seeking in general practice. However, we chose to use the CCI score since it is regarded among the best methods to measure comorbidity and that it was not possible to collect diagnoses registered in primary care since the Danish authorities made the existing database inaccessible for researchers in 2015. Secondly, we did not have the possibility of collecting information on over-the-counter sale of drugs with anticoagulatory effect (primarily NSAIDs) and information on diagnoses from general practice. This residual confounding may therefore account for some of the difference between subgroups.

The reported results on the incidence of CRC outside the screening programme are generalizable to other countries using FIT-based screening, but are dependent on participation rate and the screened age group. Furthermore, the results on diagnostic activity are generalizable to health care settings similar to the Danish.

Comparison with other research {#s0016}
------------------------------

From the present results it seems that the majority of individuals with a screen-detected CRC are not symptomatic as indicated by similar use of general practice. Thus, it seems unlikely that these individuals may be diagnosed earlier in general practice. However, previous questionnaire studies have indicated that approx. 75-80% of individuals with a positive FIT in a screening programme have lower GI symptoms \[[@CIT0004]\]. An explanation for these findings could be recall bias among individuals with a screen-detected CRC. Another explanation could be that the symptoms the patient experience are not serious enough for the patient to consult a GP. Nevertheless, our findings represent a mean for all patients. This could imply that a proportion of the population attend the GP more often before attending the screening due to gastro-intestinal symptoms. However, in this study, we cannot identify who or how many this concerns.

In the analyses comparing the diagnostic activity for participants vs. non-participants, we found that participants in screening generally had higher diagnostic activity in the years preceding screening invitation. This is supported by the literature which shows that low SES and a low use of health care services are known to be related to non-participation in screening \[[@CIT0008]\]. We therefore consider the difference a consequence of another health care seeking behaviour and a lower threshold for acting on symptoms, rather than a true difference in symptom prevalence \[[@CIT0025]\].

In line with the literature, we found that CRC occurs in general practice in the screened age group \[[@CIT0007],[@CIT0026]\]. It has been shown that individuals diagnosed with CRC in general practice attend their GP more in the year preceding the diagnosis than the background population \[[@CIT0024]\]. This may indicate a diagnostic window to detect CRC earlier. Recent studies have suggested that the FIT can be used outside screening in general practice to detect CRC in symptomatic individuals \[[@CIT0027]\]. In consideration of this, the FIT may be used in this diagnostic window to reduce the time to diagnosis. In relation to our findings, the majority of screening non-participants were individuals with low SES and high levels of comorbidity. We also saw that this population had higher frequency of positive FITs when they participated in the screening and therefore, the FIT may be a useful diagnostic tool in general practice to detect CRC in this population. However, further research is needed on this topic.

In conclusion, we did not find evidence to support that the majority of individuals with a positive FIT or CRC diagnosed in the screening programme were symptomatic. However, CRC will still occur in general practice in the screened population, and special notice has to be paid on non-participants since they are often deprived and have higher risk of late stage CRC.
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